These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 9722921)
1. Therapeutic vaccination against chronic viral infection: the importance of cooperation between CD4+ and CD8+ T cells. Zajac AJ; Murali-Krishna K; Blattman JN; Ahmed R Curr Opin Immunol; 1998 Aug; 10(4):444-9. PubMed ID: 9722921 [TBL] [Abstract][Full Text] [Related]
3. Exploiting 4-1BB costimulation for enhancing antiviral vaccination. Harrison JM; Bertram EM; Ramshaw IA Viral Immunol; 2006; 19(4):593-601. PubMed ID: 17201654 [TBL] [Abstract][Full Text] [Related]
4. IL-21 is required to control chronic viral infection. Elsaesser H; Sauer K; Brooks DG Science; 2009 Jun; 324(5934):1569-72. PubMed ID: 19423777 [TBL] [Abstract][Full Text] [Related]
5. Vaccine-induced protection against orthopoxvirus infection is mediated through the combined functions of CD4 T cell-dependent antibody and CD8 T cell responses. Chaudhri G; Tahiliani V; Eldi P; Karupiah G J Virol; 2015 Feb; 89(3):1889-99. PubMed ID: 25428875 [TBL] [Abstract][Full Text] [Related]
6. Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge. Epstein SL; Stack A; Misplon JA; Lo CY; Mostowski H; Bennink J; Subbarao K Int Immunol; 2000 Jan; 12(1):91-101. PubMed ID: 10607754 [TBL] [Abstract][Full Text] [Related]
7. A mouse model to study immunity against pseudorabies virus infection: significance of CD4+ and CD8+ cells in protective immunity. Bianchi AT; Moonen-Leusen HW; van Milligen FJ; Savelkoul HF; Zwart RJ; Kimman TG Vaccine; 1998 Oct; 16(16):1550-8. PubMed ID: 9711803 [TBL] [Abstract][Full Text] [Related]
8. Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection. Ha SJ; Mueller SN; Wherry EJ; Barber DL; Aubert RD; Sharpe AH; Freeman GJ; Ahmed R J Exp Med; 2008 Mar; 205(3):543-55. PubMed ID: 18332181 [TBL] [Abstract][Full Text] [Related]
9. Antiviral memory T cell responses: correlation with protective immunity and implication for vaccine development. Harari A; Ellefsen K; Champagne P; Nobile M; Pantaleo G Adv Exp Med Biol; 2002; 512():155-64. PubMed ID: 12405200 [No Abstract] [Full Text] [Related]
10. Manipulating both the inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections. Ha SJ; West EE; Araki K; Smith KA; Ahmed R Immunol Rev; 2008 Jun; 223():317-33. PubMed ID: 18613845 [TBL] [Abstract][Full Text] [Related]
11. Low CD8 T-cell proliferative potential and high viral load limit the effectiveness of therapeutic vaccination. Wherry EJ; Blattman JN; Ahmed R J Virol; 2005 Jul; 79(14):8960-8. PubMed ID: 15994790 [TBL] [Abstract][Full Text] [Related]
12. From crucial to negligible: functional CD8⁺ T-cell responses and their dependence on CD4⁺ T-cell help. Wiesel M; Oxenius A Eur J Immunol; 2012 May; 42(5):1080-8. PubMed ID: 22539281 [TBL] [Abstract][Full Text] [Related]
13. Functional signatures of protective antiviral T-cell immunity in human virus infections. Harari A; Dutoit V; Cellerai C; Bart PA; Du Pasquier RA; Pantaleo G Immunol Rev; 2006 Jun; 211():236-54. PubMed ID: 16824132 [TBL] [Abstract][Full Text] [Related]
14. Costimulation in antiviral immunity: differential requirements for CD4(+) and CD8(+) T cell responses. Whitmire JK; Ahmed R Curr Opin Immunol; 2000 Aug; 12(4):448-55. PubMed ID: 10899032 [TBL] [Abstract][Full Text] [Related]
15. Rapid whole blood analysis of virus-specific CD4 and CD8 T cell responses in persistent HIV infection. Sester M; Sester U; Köhler H; Schneider T; Deml L; Wagner R; Mueller-Lantzsch N; Pees HW; Meyerhans A AIDS; 2000 Dec; 14(17):2653-60. PubMed ID: 11125883 [TBL] [Abstract][Full Text] [Related]
16. Assessment of human CD4+ and CD8+ T lymphocyte responses in experimental viral vaccine studies. Rothman AL; Yamada Y; Jameson J; Cruz J; West K; Green S; Ennis FA Dev Biol Stand; 1998; 95():95-104. PubMed ID: 9855419 [TBL] [Abstract][Full Text] [Related]
17. Antibody-independent antiviral function of memory CD4+ T cells in vivo requires regulatory signals from CD8+ effector T cells. Zhong W; Roberts AD; Woodland DL J Immunol; 2001 Aug; 167(3):1379-86. PubMed ID: 11466356 [TBL] [Abstract][Full Text] [Related]
18. CD4(+) T-cell dependence of primary CD8(+) T-cell response against vaccinia virus depends upon route of infection and viral dose. Hu Z; Molloy MJ; Usherwood EJ Cell Mol Immunol; 2016 Jan; 13(1):82-93. PubMed ID: 25544501 [TBL] [Abstract][Full Text] [Related]
19. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients. Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965 [TBL] [Abstract][Full Text] [Related]
20. Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infection. Knuschke T; Rotan O; Bayer W; Sokolova V; Hansen W; Sparwasser T; Dittmer U; Epple M; Buer J; Westendorf AM Retrovirology; 2016 Apr; 13():24. PubMed ID: 27076190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]